Global Spatial Genomics and Transcriptomics Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Spatial Genomics and Transcriptomics Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Spatial genomics & transcriptomics is a relatively new discipline that involves the determination of high-throughput data pertaining to the organizational structure of cell content from tissue and cell specimens. Conventional genomic techniques lose positional information of the nucleic acid content, which has been addressed by the advent of this technology.

Market Overview:


The latest research study on the global Spatial Genomics and Transcriptomics market finds that the global Spatial Genomics and Transcriptomics market reached a value of USD 252.51 million in 2022. It’s expected that the market will achieve USD 423.61 million by 2028, exhibiting a CAGR of 9.01% during the forecast period.

Technology advancement

Spatial transcriptomics is a groundbreaking technology that allows scientists to measure all the gene activity in a tissue sample and map where the activity is occurring. Already this technology is leading to new discoveries that will prove instrumental in helping scientists gain a better understanding of biological processes and diseases. It involves the determination of high-throughput data pertaining to the organizational structure of cell content from tissue and cell specimens. Conventional genomic techniques lose positional information on the nucleic acid content, which has been addressed by the advent of this technology. Its intrinsic benefit promises to bring the market huge potential. Besides, rapid advancements in the genomics arena, ranging from tissue sequencing to single-cell sequencing and techniques, have significantly enhanced spatial genomic sequencing techniques. This is because single-cell sequencing enables the identification of the spatial origin of cells to characterize complex tissues. Moreover, the advent of the fourth generation of sequencing also provides the spatial genomics and transcriptomic market with huge potential. In spatial transcriptomics, sequencing techniques held a major share due to the wide availability of sequencing platforms that help study RNA architecture in tissues or cells. Sequencing technology boasts accurate and short reading time. The fast and cheap DNA sequencing capabilities will make genomics a routine method for studying biological problems, and the adoption rate of sequencing techniques for identification of the spatial distribution of reads in a sample is increasing, so as to promote the market development. Moreover, improvements in data generation and analysis will bring spatial transcriptomics into wider practice and will be transformative for biology.

Limited technological progress

While certainly promising, there do exist some challenges in the application of spatial genomics. For instance, identifying and validating the right biomarkers for a specific disease state, merging sequencing data with imaging readouts, visualizing the phenotype of a tissue section, and accurately capturing the cell state and identifying the role of that cell in the tissue microenvironment, all have some limitations that are being looked at. As new applications for spatial genomics and transcriptomics continue to emerge, the need to expand the number of assays and analysis tools and to make them more economical, efficient, and unbiased is also underway. Similarly, there is a need to increase the resolution, scale, and types of information that can be measured in a spatial context. Robust, reproducible assays and standardized protocols designed for analysis of tissue will be needed to enable implementation of spatial genomics in a wide variety of laboratory settings and to facilitate cross comparison of datasets generated across different labs and timepoints.

Region Overview:


North America dominated the Spatial Genomics and Transcriptomics market in 2021, with a market share of 44.84%.

Segmentation Overview:


Among different product types, Spatial Genomics segment is anticipated to contribute the largest market share in 2027.

Spatial Genomics

Spatial Genomics is an interdisciplinary field of biology focusing on the structure, function, evolution, mapping, and editing of genomes. A genome is an organism's complete set of DNA, including all of its genes.

Transcriptomics

Transcriptomics is the study of the transcriptome-the complete set of RNA transcripts that are produced by the genome, under specific circumstances or in a specific cell-using high-throughput methods, such as microarray analysis.

Application Overview:


By application, the Laboratory segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Spatial Genomics and Transcriptomics market covered in Chapter 3:

READCOOR, INC.
CARTANA AB
Illumina, Inc.
10x Genomics
Natera Inc.
Seven Bridges Genomics
NanoString Technologies, Inc.
S2 Genomics, Inc.
Bio-Techne
Dovetail Genomics
Horizon Discovery Group plc

In Chapter 4 and Chapter 14.2, on the basis of types, the Spatial Genomics and Transcriptomics market from 2018 to 2029 is primarily split into:

Spatial Genomics
Transcriptomics
Proteomics

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Spatial Genomics and Transcriptomics market from 2018 to 2029 covers:

Hospital
Laboratory

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)